WallStSmart

Ainos Inc (AIMD)vsCoherent Inc (COHR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 5677109% more annual revenue ($6.29B vs $110,870). COHR leads profitability with a 4.7% profit margin vs 0.0%. COHR appears more attractively valued with a PEG of 0.92. COHR earns a higher WallStSmart Score of 52/100 (C-).

AIMD

Hold

40

out of 100

Grade: D

Growth: 3.3Profit: 2.5Value: 6.7Quality: 6.0
Piotroski: 2/9Altman Z: -3.48

COHR

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 4.7Quality: 6.3
Piotroski: 5/9Altman Z: 1.53
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AIMD.

COHRSignificantly Overvalued (-373.2%)

Margin of Safety

-373.2%

Fair Value

$47.27

Current Price

$272.04

$224.77 premium

UndervaluedFair: $47.27Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIMD2 strengths · Avg: 9.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

PEG RatioValuation
0.938/10

Growing faster than its price suggests

COHR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$51.06B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Revenue GrowthGrowth
17.5%8/10

17.5% revenue growth

Areas to Watch

AIMD4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.1%4/10

4.1% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$12.31M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

COHR4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

P/E RatioValuation
269.6x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : AIMD

The strongest argument for AIMD centers on Price/Book, PEG Ratio. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : COHR

The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 17.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bear Case : AIMD

The primary concerns for AIMD are Revenue Growth, EPS Growth, Market Cap.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 269.6x leaves little room for execution misses. Thin 4.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

AIMD profiles as a value stock while COHR is a growth play — different risk/reward profiles.

AIMD carries more volatility with a beta of 2.37 — expect wider price swings.

COHR is growing revenue faster at 17.5% — sustainability is the question.

AIMD generates stronger free cash flow (-1M), providing more financial flexibility.

Bottom Line

COHR scores higher overall (52/100 vs 40/100) and 17.5% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ainos Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Want to dig deeper into these stocks?